Cigna is doubling down on its efforts to manage the challenges associated with GLP-1s through the launch of two new programs. The first, called EnReachRx, is a new patient support program designed ...

Investing.com -- Cigna Group is contending with elevated industry-wide medical costs that are expected to weigh on its Healthcare segment in 2025, according to CFRA, which downgraded the stock to ...

The Cigna Group has completed the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC) for $3.3 billion.

The Cigna Group reported a strong start to the year, with first-quarter 2025 revenues rising 14% to $65.5 billion, driven by growth in its Evernorth Health Services and Cigna Healthcare segments.

Cigna is building on client demand for tools to support patients on GLP-1 weight loss drugs, announcing two new programs on Friday meant to improve clinical care around the dispensing of GLP-1s ...

Pharmacy Benefit Services Revenue Growth: 14% increase. Cigna Healthcare Revenue: $14.5 billion for the first quarter. Cigna Healthcare Pretax Adjusted Earnings: $1.3 billion. Medical Care Ratio ...